Multiple Sclerosis, Rituximab, Hypogammaglobulinemia and Risk of Infections
Neurology Minute · American Academy of Neurology
March 29, 20244m 4s
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Dr. Shuvro Roy and Dr. Annette Langer-Gould discuss the effective dose of rituximab and other B-cell depleting therapies in patients with multiple sclerosis, as well as important comorbidities to prevent infection risks.
Show reference: